# Boston Scientific to acquire up to 65% stake in Acandis Holdings via partial tender offer

Boston Scientific announced a partial tender offer to acquire up to 203,702,962 shares (65% equity) of Acandis Holdings Limited at HK$20 per share, with a maximum offer value of approximately HK$4.07 billion. The offer includes a strategic collaboration in China.

- Type: Acquisition
- Announced: 2022-12-12
- Where: Hong Kong SAR China
- Value: $522.0M (4.07B HKD)
- Status: announced
- Products: medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Acandis Holdings](https://endata.com/companies/67258.md) (target)

## Sources

- [vcbeathealth.com](https://www.vcbeathealth.com/article/37856), 2022-12-12: "AcoMed Holdings Limited and Boston Scientific Corporation Announce Partial Tender Offer and Strategic Collaboration."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
